rs771115907
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_004064.5(CDKN1B):c.425C>A(p.Thr142Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000121 in 1,568,634 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T142M) has been classified as Likely benign.
Frequency
Consequence
NM_004064.5 missense
Scores
Clinical Significance
Conservation
Publications
- multiple endocrine neoplasia type 4Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, ClinGen
- multiple endocrine neoplasiaInheritance: AD Classification: STRONG Submitted by: G2P
- hereditary nonpolyposis colon cancerInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDKN1B | NM_004064.5 | c.425C>A | p.Thr142Lys | missense_variant | Exon 1 of 3 | ENST00000228872.9 | NP_004055.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CDKN1B | ENST00000228872.9 | c.425C>A | p.Thr142Lys | missense_variant | Exon 1 of 3 | 1 | NM_004064.5 | ENSP00000228872.4 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151326Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000409 AC: 1AN: 244494 AF XY: 0.00000753 show subpopulations
GnomAD4 exome AF: 0.0000120 AC: 17AN: 1417308Hom.: 0 Cov.: 38 AF XY: 0.0000156 AC XY: 11AN XY: 705846 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151326Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 73914 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Multiple endocrine neoplasia type 4 Uncertain:1
This sequence change replaces threonine, which is neutral and polar, with lysine, which is basic and polar, at codon 142 of the CDKN1B protein (p.Thr142Lys). This variant is present in population databases (rs771115907, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with CDKN1B-related conditions. ClinVar contains an entry for this variant (Variation ID: 824731). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.T142K variant (also known as c.425C>A), located in coding exon 1 of the CDKN1B gene, results from a C to A substitution at nucleotide position 425. The threonine at codon 142 is replaced by lysine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at